The global pharmaceutical water market size accounted for USD 42.95 billion in 2024, grew to USD 47.47 billion in 2025 and is projected to surpass around USD 99.30 billion by 2034, representing a healthy CAGR of 8.74% between 2024 and 2034. The North America pharmaceutical water market size is calculated at USD 14.97 billion in 2024 and is expected to grow at a fastest CAGR of 8.88% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Covid-19: Pharmaceutical Water Industry Impact
5.2. Pharmaceutical Water Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Pharmaceutical Water Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Pharmaceutical Water Market Players to deal with Covid-19 Pandemic Scenario
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Driver 1
6.1.1.2. Driver 2
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Pharmaceutical Water Market Revenue by Market Players
7.1.1.2. Pharmaceutical Water Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users
8.1. Pharmaceutical Water Market, by Product Type, 2024-2033
8.1.1. HPLC Grade Water
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Water for Injection
8.1.2.1. Market Revenue and Forecast (2021-2033)
9.1. Pharmaceutical Water Market, by Application, 2024-2033
9.1.1. Pharmaceutical & Biotechnology Companies
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Academics & Research Laboratories
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2021-2033)
10.1. North America
10.1.1. Market Revenue Forecast by Product Type(2021-2033)
10.1.2. Market Revenue Forecast by Application (2021-2033)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2021-2033)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2021-2033)
10.2. Europe
10.2.1. Market Revenue Forecast by Product Type(2021-2033)
10.2.2. Market Revenue Forecast by Application (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2021-2033)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2021-2033)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product Type(2021-2033)
10.3.2. Market Revenue Forecast by Application (2021-2033)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2021-2033)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2021-2033)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product Type(2021-2033)
10.4.2. Market Revenue Forecast by Application (2021-2033)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2021-2033)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2021-2033)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product Type(2021-2033)
10.5.2. Market Revenue Forecast by Application (2021-2033)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2021-2033)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2021-2033)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2021-2033)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2021-2033)
11.1. Baxter International, Inc.
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin
11.1.4. Recent Developments and Strategies
11.2. Merck KGaA
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin
11.2.4. Recent Developments and Strategies
11.3. B. Braun Melsungen AG
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin
11.3.4. Recent Developments and Strategies
11.4. Thermo Fisher Scientific, Inc
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin
11.4.4. Recent Developments and Strategies
11.5. Cytiva (Danaher)
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin
11.5.4. Recent Developments and Strategies
11.6. Fresenius Kabi AG
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin
11.6.4. Recent Developments and Strategies
11.7. Pfizer, Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin
11.7.4. Recent Developments and Strategies
11.8. CovaChem, LLC
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin
11.8.4. Recent Developments and Strategies
11.9. Intermountain Life Sciences
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin
11.9.4. Recent Developments and Strategies
11.10. Standard Reagents, Pvt. Ltd
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin
11.10.4. Recent Developments and Strategies
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample